94 related articles for article (PubMed ID: 31093512)
1. Calcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1
Martínez-Reza I; Díaz L; Barrera D; Segovia-Mendoza M; Pedraza-Sánchez S; Soca-Chafre G; Larrea F; García-Becerra R
J Immunol Res; 2019; 2019():6384278. PubMed ID: 31093512
[TBL] [Abstract][Full Text] [Related]
2. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.
Chang CM; Liang TR; Lam HYP
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254674
[TBL] [Abstract][Full Text] [Related]
3. Ex Vivo Immune Function and Modulatory Effects of Calcitriol in Dogs with Naturally Occurring Diabetes Mellitus.
Jaffey JA; Kreisler R; Graves TK; Al-Nakkash L; Backus RC; Allison L
Vet Sci; 2024 Apr; 11(5):. PubMed ID: 38787165
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Eyre R; Alférez DG; Santiago-Gómez A; Spence K; McConnell JC; Hart C; Simões BM; Lefley D; Tulotta C; Storer J; Gurney A; Clarke N; Brown M; Howell SJ; Sims AH; Farnie G; Ottewell PD; Clarke RB
Nat Commun; 2019 Nov; 10(1):5016. PubMed ID: 31676788
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β and Cancer.
Rébé C; Ghiringhelli F
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635472
[TBL] [Abstract][Full Text] [Related]
6. IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model.
Gomes T; Várady CBS; Lourenço AL; Mizurini DM; Rondon AMR; Leal AC; Gonçalves BS; Bou-Habib DC; Medei E; Monteiro RQ
Front Immunol; 2019; 10():2088. PubMed ID: 31552036
[TBL] [Abstract][Full Text] [Related]
7. EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.
Achounna AS; Ordaz-Rosado D; García-Quiroz J; Morales-Guadarrama G; Milo-Rocha E; Larrea F; Díaz L; García-Becerra R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542136
[TBL] [Abstract][Full Text] [Related]
8. The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy.
Khamis A; Salzer L; Schiegnitz E; Stauber RH; Gül D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894739
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor.
Jaratsittisin J; Sornjai W; Chailangkarn T; Jongkaewwattana A; Smith DR
PLoS One; 2023; 18(10):e0293010. PubMed ID: 37847693
[TBL] [Abstract][Full Text] [Related]
10. The impact of vitamin D on cancer: A mini review.
Seraphin G; Rieger S; Hewison M; Capobianco E; Lisse TS
J Steroid Biochem Mol Biol; 2023 Jul; 231():106308. PubMed ID: 37054849
[TBL] [Abstract][Full Text] [Related]
11. Establishment of triple-negative breast cancer cells based on BMI: A novel model in the correlation between obesity and breast cancer.
Shveid Gerson D; Gerson-Cwilich R; Lara Torres CO; Chousleb de Kalach A; Ventura Gallegos JL; Badillo-Garcia LE; Bargalló Rocha JE; Maffuz-Aziz A; Sánchez Forgach ER; Castorena Roji G; Robles Vidal CD; Vargas-Castillo A; Torres N; Tovar AR; Contreras Jarquín M; Gómez Osnaya JT; Zentella-Dehesa A
Front Oncol; 2022; 12():988968. PubMed ID: 36591465
[TBL] [Abstract][Full Text] [Related]
12. Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple-Negative Breast Cancer Cell Lines.
Wong FH; Palanirajan VK; Ng ESC; Tan CK; Tan ESS; Amini F
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145297
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D: an essential adjuvant therapeutic agent in breast cancer.
Thabet RH; Gomaa AA; Matalqah LM; Shalaby EM
J Int Med Res; 2022 Jul; 50(7):3000605221113800. PubMed ID: 35883275
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma.
Li T; Liu H; Dong C; Lyu J
Front Pharmacol; 2022; 13():806995. PubMed ID: 35153782
[No Abstract] [Full Text] [Related]
15. High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.
Liu J; Shen J; Mu C; Liu Y; He D; Luo H; Wu W; Zheng X; Liu Y; Chen S; Pan Q; Hu Y; Ni Y; Wang Y; Liu Y; Li Z
Bioeng Transl Med; 2022 Jan; 7(1):e10263. PubMed ID: 35111955
[TBL] [Abstract][Full Text] [Related]
16. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Bruchard M; Geindreau M; Perrichet A; Truntzer C; Ballot E; Boidot R; Racoeur C; Barsac E; Chalmin F; Hibos C; Baranek T; Paget C; Ryffel B; Rébé C; Paul C; Végran F; Ghiringhelli F
Nat Immunol; 2022 Feb; 23(2):262-274. PubMed ID: 35102345
[TBL] [Abstract][Full Text] [Related]
17. Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.
Liu F; Li L; Lan M; Zou T; Kong Z; Cai T; Wu XY; Cai Y
Mediators Inflamm; 2021; 2021():7785890. PubMed ID: 34602858
[TBL] [
